Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease.
Lichnog C, Klabunde S, Becker E, Fuh F, Tripal P, Atreya R, Klenske E, Erickson R, Chiu H, Reed C, Chung S, Neufert C, Atreya I, McBride J, Neurath MF, Zundler S.
Lichnog C, et al. Among authors: chung s.
Front Pharmacol. 2019 Feb 1;10:39. doi: 10.3389/fphar.2019.00039. eCollection 2019.
Front Pharmacol. 2019.
PMID: 30774593
Free PMC article.